**Abstract**

It has been widely reported regarding relationship between depression and cognitive function. Benzodiazepines (BZD) has been reported that there is risk by which it itself has an influence on the cognitive function. The aim of the present study was to clarify whether BZD influenced to the cognitive impairment in remitted depression.

Patients had previously met DSM-IV criteria for Major Depressive Disorder (MDD), who had not taken tricyclic antidepressants (TCA). At immediately after remission defined as a score ≦ 7 on HAM-D, we divided MDD patients into taking or not taking BZD. BZD group (n = 98) and non-BZD group (n = 89) and healthy controls (n =311) were recruited. Cognitive functions were measured using the Logical memory (LM) subtest of the Wechsler Memory Scale Revised (WMS-R) and Stroop Color and Word Test (Stroop). And score of cognitive tests were compared between the three groups.

In results, scores of LM and Stroop in BZD and non-BZD groups were decreased significantly compared with those in healthy subjects group (p \< 0.001, Mann-Whitney U). However, in comparison between BZD and non-BZD groups on Stroop, there was not significant difference. For multiple regression analysis, scores of LM and Stroop were not affected with daily doses of BZD.

In conclusions, cognitive function in patients treated with BZD may not be different from those in patients treated without BZD. Thus, our findings may suggest that cognitive function in even medicated depression without BZD did not improve to healthy levels after remission.
